UNSPSC 51161541: Fluprofylline

This classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula C22H26FN5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6Y42K4JRBJ, chemically known as 1h-purine-2,6-dione, 7-(3-(4-(4-fluorobenzoyl)-1-piperidinyl)propyl)-3,7-dihydro-1,3-dimethyl- but generally known as fluprofylline, which bears US NIH Compound Identifier 65636. European Medicines Agency schedules Fluprofylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07738MIG.

UNSPSC 51161541 Fluprofylline is a Commodity code for a pharmaceutical active ingredient used in respiratory and cardiovascular therapeutics. State and local procurement activity under this code centers on bulk pharmaceutical procurement by public health departments, correctional health systems, and county medical facilities purchasing fluprofylline for inpatient and outpatient clinical use. The issuing bodies are primarily state health departments and county jail medical programs; school districts and municipalities do not typically solicit this ingredient directly, as procurement routes through state pharmaceutical contracts and group purchasing organizations that aggregate demand across multiple public health systems.

The source provided contains no recent state or local contract opportunities for fluprofylline; the available data does not support identification of geographic concentration, representative recent solicitations, notice types, or response dates.